Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults (Q43282979)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 August 2009

Language	Label	Description	Also known as
English	Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults	scientific article published on 29 August 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

Rodrigo Valera

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Hilda María García

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Manuel Díaz Jidy

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Mayelin Mirabal

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Marlene Isabel Armesto

5

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Rafael Fando

6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Luis García

7

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Roberto Fernández

8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Gemma Año

9

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Bárbara Cedré

10

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Margarita Ramírez

11

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Laura Bravo

12

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Teresita Serrano

13

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sara Palma

14

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Daniel González

15

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Fernando Miralles

16

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Vilma Medina

17

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Felicita Nuñez

18

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Yilian Plasencia

19

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Juan Carlos Martínez

20

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Aleyda Mandarioti

21

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Juan Lugones

22

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Boris Luis Rodríguez

23

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Arlenis Moreno

24

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Domingo González

25

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Morelia Baro

26

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Rosa Lidia Solis

27

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Gustavo Sierra

28

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Ramón Barbera

29

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Francisco Domínguez

30

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Carlos Gutiérrez

31

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Gustavo Kouri

32

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Concepción Campa

33

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Jorge Menéndez

34

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

language of work or name

0 references

publication date

29 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

6564-6569

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Vaccination strategies for mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Approximate Is Better than "Exact" for Interval Estimation of Binomial Proportions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Duration of infection-derived immunity to cholera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Role of secretory antibodies in the defence against infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.08.042

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43282979&oldid=1985555588"